921 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $164.04 $54.56B Downtrend
Article Searches
Stocks making the biggest moves premarket: GM, AGN, TPR, CNC, WCG, BDX & more https://www.cnbc.com/2018/02/06/stocks-making-the-biggest-moves-premarket-gm-agn-tpr-cnc-wcg-bdx-more.html Feb 06, 2018 - Names on the move ahead of the open.
Barrage Capital Fund 2017 Annual Letter https://seekingalpha.com/article/4143423-barrage-capital-fund-2017-annual-letter?source=feed_all_articles Feb 06, 2018 - Includes detailed analysis of Barrage Capital Fund's positions in CHTR, AMZN, BT, AGN, C, GM, AN, AIG, BCS.In 2017, the S&P/TSX index generated a return of 9.02% (including dividends), while the S&P 5
Antifragility, Path Dependency, And Value Investing (Part 1) https://seekingalpha.com/article/4143406-antifragility-path-dependency-value-investing-part-1?source=feed_all_articles Feb 06, 2018 - Today, I am going to do something we rarely do. I will share a large excerpt from IMA's last quarterly letter to clients. Our quarterly letters are somewhat unconventional in that they provide an in-d
Allergan (AGN) Q4 Earnings Beat on Increase in Botox Sales http://www.zacks.com/stock/news/291517/allergan-agn-q4-earnings-beat-on-increase-in-botox-sales?cid=CS-ZC-FT-291517 Feb 06, 2018 - Allergan (AGN) beats expectations for both earnings and revenues in Q4. A phase III study evaluating Allergan's migraine candidate, ubrogepant meets its co-primary endpoints.
Patent Losses Could Sink Allergan https://seekingalpha.com/article/4143256-patent-losses-sink-allergan?source=feed_tag_short_ideas Feb 05, 2018 - AGN reports Q4 earnings Tuesday.The company faces patent losses for Restasis, Combigan and Estrace. They represent a combined 15% of total revenue.LOE and a potential decline in sentiment could sink A
Equity Versus Debt: A Showdown https://seekingalpha.com/article/4143240-equity-versus-debt-showdown?source=feed_all_articles Feb 05, 2018 - Explains the equity multiplier and the debt ratio and demonstrates that the way we use them is all wrong.Enumerates some of the costs and risks of equity funding.Problematizes using book value as a fo
Fishman Jay A Ltd Buys Intel Corp, Lennar Corp, General Motors Co, Sells Allergan PLC, Celgene ... http://www.gurufocus.com/news/635498/fishman-jay-a-ltd-buys-intel-corp-lennar-corp-general-motors-co-sells-allergan-plc-celgene-corp-starbucks-corp Feb 05, 2018 - Fishman Jay A Ltd Buys Intel Corp, Lennar Corp, General Motors Co, Sells Allergan PLC, Celgene Corp, Starbucks Corp, Stocks: INTC,LEN,GM,EXP,BAC,IBB,F,VV,SU,AGN,SBUX,CVS,NWL,C, release date:Feb 05, 2018
A $700 Million Gift Will Not Stop Teva's Slide https://seekingalpha.com/article/4143170-700-million-gift-will-stop-tevas-slide?source=feed_sector_healthcare Feb 05, 2018 - TEVA received $700MM from AGN to settle a dispute related to the acquisition of AGN's generics business.TEVA's credit metrics and share price will likely deteriorate despite the payment.TEVA remains a
What Can We Do Now? Part II http://www.gurufocus.com/news/634601/what-can-we-do-now-part-ii Feb 04, 2018 - What Can We Do Now? Part II, Stocks: AGN,BRK.B,DHR,DJCO,GOOGL,KHC,MKL,PEP, Howard Marks,Charlie Munger, release date:Feb 04, 2018
Biotech Forum Daily Digest For February 3rd https://seekingalpha.com/article/4142881-biotech-forum-daily-digest-february-3rd?source=feed_sector_healthcare Feb 03, 2018 - The biotech sector is plummeting with the rest of the market this week trapped within a 'hiccup' that hits equities from time to time. The sector is basically given back last week's large gains and th

Pages: 123456789...93

<<<Page 4>